EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Philogen Spa's enterprise value is €668.01 Mil.
Philogen Spa's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €23.13 Mil. Therefore, Philogen Spa's EV-to-Revenue for today is 28.88.
The historical rank and industry rank for Philogen Spa's EV-to-Revenue or its related term are showing as below:
STU:78Q'
s EV-to-Revenue Range Over the Past 10 Years
Min: 20.67 Med: 98.17 Max: 202.75
Current: 28.87
During the past 4 years, the highest EV-to-Revenue of Philogen Spa was 202.75. The lowest was 20.67. And the median was 98.17.
STU:78Q's EV-to-Revenue is ranked worse than 72.99% of 1033
companies
in the Biotechnology industry
Industry Median: 7.68
vs STU:78Q: 28.87
As of today (2024-04-26), Philogen Spa's stock price is €17.85.
Philogen Spa's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.57. Therefore, Philogen Spa's PS Ratio for today is 31.15.
Philogen Spa EV-to-Revenue Historical Data
The historical data trend for Philogen Spa's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Philogen Spa's EV-to-Revenue
For the Biotechnology subindustry, Philogen Spa's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Philogen Spa's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Philogen Spa's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Philogen Spa's EV-to-Revenue falls into.
Philogen Spa's current Enterprise Value is €668.01 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Philogen Spa's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €23.13 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Philogen Spa's share price for today is €17.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.57.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Philogen Spa EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Philogen Spa's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, it derives a majority of revenue from the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:78Q has been successfully added to your